1. Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study. (16th August 2021) Authors: Zalcberg, John R.; Heinrich, Michael C.; George, Suzanne; Bauer, Sebastian; Schöffski, Patrick; Serrano, César; Gelderblom, Hans; Jones, Robin L.; Attia, Steven; D'Amato, Gina; Chi, Ping; Reichardt, Peter; Somaiah, Neeta; Meade, Julie; Reichert, Vienna; Shi, Kelvin; Sherman, Matthew L.; Ruiz-Soto... Journal: Oncologist Issue: Volume 26:Number 11(2021) Page Start: e2053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study. (16th August 2021) Authors: Zalcberg, John R.; Heinrich, Michael C.; George, Suzanne; Bauer, Sebastian; Schöffski, Patrick; Serrano, César; Gelderblom, Hans; Jones, Robin L.; Attia, Steven; D'Amato, Gina; Chi, Ping; Reichardt, Peter; Somaiah, Neeta; Meade, Julie; Reichert, Vienna; Shi, Kelvin; Sherman, Matthew L.; Ruiz‐Soto... Journal: Oncologist Issue: Volume 26:Number 11(2021) Page Start: e2053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of CYP3A Inhibition, CYP3A Induction, and Gastric Acid Reduction on the Pharmacokinetics of Ripretinib, a Switch Control KIT Tyrosine Kinase Inhibitor. Issue 10 (13th May 2022) Authors: Li, Xiaoyan; Shelton, Mark J; Wang, Jing; Meade, Julie; Ruiz‐Soto, Rodrigo Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 10(2022) Page Start: 1165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial. Issue 7 (July 2020) Authors: Blay, Jean-Yves; Serrano, César; Heinrich, Michael C; Zalcberg, John; Bauer, Sebastian; Gelderblom, Hans; Schöffski, Patrick; Jones, Robin L; Attia, Steven; D'Amato, Gina; Chi, Ping; Reichardt, Peter; Meade, Julie; Shi, Kelvin; Ruiz-Soto, Rodrigo; George, Suzanne; von Mehren, Margaret Journal: Lancet oncology Issue: Volume 21:Issue 7(2020) Page Start: 923 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial. Issue 34 (1st December 2022) Authors: Bauer, Sebastian; Jones, Robin L.; Blay, Jean-Yves; Gelderblom, Hans; George, Suzanne; Schöffski, Patrick; von Mehren, Margaret; Zalcberg, John R.; Kang, Yoon-Koo; Razak, Albiruni Abdul; Trent, Jonathan; Attia, Steven; Le Cesne, Axel; Su, Ying; Meade, Julie; Wang, Tao; Sherman, Matthew L.; Ruiz-S... Journal: Journal of clinical oncology Issue: Volume 40:Issue 34(2022) Page Start: 3918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗